Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Tivity Health

BST:AFN
Snowflake Description

High growth potential and slightly overvalued.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
AFN
BST
$305M
Market Cap
  1. Home
  2. DE
  3. Healthcare
Company description

Tivity Health, Inc. provides fitness, nutrition, and social connection solutions in the United States. The last earnings update was 34 days ago. More info.


Add to Portfolio Compare Print
  • Tivity Health has significant price volatility in the past 3 months.
AFN Share Price and Events
7 Day Returns
-7%
BST:AFN
8.4%
DE Healthcare
9.9%
DE Market
1 Year Returns
-62.9%
BST:AFN
-25.6%
DE Healthcare
-17.5%
DE Market
AFN Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Tivity Health (AFN) -7% -50.4% -66.9% -62.9% -77.7% -
DE Healthcare 8.4% -16.2% -21.1% -25.6% -43.3% -32%
DE Market 9.9% -16.6% -24.8% -17.5% -24.5% -28.1%
1 Year Return vs Industry and Market
  • AFN underperformed the Healthcare industry which returned -25.6% over the past year.
  • AFN underperformed the Market in Germany which returned -17.5% over the past year.
Price Volatility
AFN
Industry
5yr Volatility vs Market

AFN Value

 Is Tivity Health undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Tivity Health to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Tivity Health.

BST:AFN Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 8 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 10.5%
Perpetual Growth Rate 10-Year DE Government Bond Rate -0.4%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for BST:AFN
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year DE Govt Bond Rate -0.4%
Equity Risk Premium S&P Global 5.4%
Healthcare Unlevered Beta Simply Wall St/ S&P Global 0.66
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.657 (1 + (1- 21%) (364.2%))
2.038
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
2
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.39% + (2 * 5.44%)
10.49%

Discounted Cash Flow Calculation for BST:AFN using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Tivity Health is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

BST:AFN DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (USD, Millions) Source Present Value
Discounted (@ 10.49%)
2020 94.71 Analyst x4 85.72
2021 118.73 Analyst x4 97.25
2022 112.10 Analyst x2 83.11
2023 155.00 Analyst x1 104.00
2024 156.40 Analyst x1 94.98
2025 157.12 Est @ 0.46% 86.36
2026 157.44 Est @ 0.21% 78.32
2027 157.49 Est @ 0.03% 70.90
2028 157.33 Est @ -0.1% 64.11
2029 157.04 Est @ -0.19% 57.91
Present value of next 10 years cash flows $822.00
BST:AFN DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= $157.04 × (1 + -0.39%) ÷ (10.49% – -0.39%)
$1,437.75
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= $1,437.75 ÷ (1 + 10.49%)10
$530.22
BST:AFN Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= $822.00 + $530.22
$1,352.22
Equity Value per Share
(USD)
= Total value / Shares Outstanding
= $1,352.22 / 48.43
$27.92
BST:AFN Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in BST:AFN represents 0.95353x of NasdaqGS:TVTY
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.95353x
Value per Share
(Listing Adjusted, EUR)
= Value per Share (USD) x Listing Adjustment Factor
= $ 27.92 x 0.95353
€26.62
Value per share (EUR) From above. €26.62
Current discount Discount to share price of €5.95
= -1 x (€5.95 - €26.62) / €26.62
77.7%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Tivity Health is available for.
Intrinsic value
>50%
Share price is €5.95 vs Future cash flow value of €26.62
Current Discount Checks
For Tivity Health to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Tivity Health's share price is below the future cash flow value, and at a moderate discount (> 20%).
  • Tivity Health's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Tivity Health's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Tivity Health's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
BST:AFN PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in USD $-6.17
NasdaqGS:TVTY Share Price ** NasdaqGS (2020-03-31) in USD $6.24
Germany Healthcare Industry PE Ratio Median Figure of 9 Publicly-Listed Healthcare Companies 27.51x
Germany Market PE Ratio Median Figure of 399 Publicly-Listed Companies 16.31x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Tivity Health.

BST:AFN PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= NasdaqGS:TVTY Share Price ÷ EPS (both in USD)

= 6.24 ÷ -6.17

-1.01x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Tivity Health is loss making, we can't compare its value to the DE Healthcare industry average.
  • Tivity Health is loss making, we can't compare the value of its earnings to the Germany market.
Price based on expected Growth
Does Tivity Health's expected growth come at a high price?
Raw Data
BST:AFN PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section -1.01x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 8 Analysts
129.1%per year
Germany Healthcare Industry PEG Ratio Median Figure of 7 Publicly-Listed Healthcare Companies 1.22x
Germany Market PEG Ratio Median Figure of 255 Publicly-Listed Companies 1.18x

*Line of best fit is calculated by linear regression .

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to calculate PEG ratio for Tivity Health, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on Tivity Health's assets?
Raw Data
BST:AFN PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in USD $4.71
NasdaqGS:TVTY Share Price * NasdaqGS (2020-03-31) in USD $6.24
Germany Healthcare Industry PB Ratio Median Figure of 14 Publicly-Listed Healthcare Companies 1.13x
Germany Market PB Ratio Median Figure of 571 Publicly-Listed Companies 1.43x
BST:AFN PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= NasdaqGS:TVTY Share Price ÷ Book Value per Share (both in USD)

= 6.24 ÷ 4.71

1.32x

* Primary Listing of Tivity Health.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Tivity Health is overvalued based on assets compared to the DE Healthcare industry average.
X
Value checks
We assess Tivity Health's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Healthcare industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Healthcare industry average (and greater than 0)? (1 check)
  5. Tivity Health has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

AFN Future Performance

 How is Tivity Health expected to perform in the next 1 to 3 years based on estimates from 8 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
129.1%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Tivity Health expected to grow at an attractive rate?
  • Tivity Health's earnings growth is expected to exceed the low risk savings rate of -0.4%.
Growth vs Market Checks
  • Tivity Health's earnings growth is expected to exceed the Germany market average.
  • Tivity Health's revenue growth is expected to exceed the Germany market average.
Annual Growth Rates Comparison
Raw Data
BST:AFN Future Growth Rates Data Sources
Data Point Source Value (per year)
BST:AFN Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 8 Analysts 129.1%
BST:AFN Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 8 Analysts 6.6%
Germany Healthcare Industry Earnings Growth Rate Market Cap Weighted Average 9.4%
Germany Healthcare Industry Revenue Growth Rate Market Cap Weighted Average 5.5%
Germany Market Earnings Growth Rate Market Cap Weighted Average 14.4%
Germany Market Revenue Growth Rate Market Cap Weighted Average 4.1%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
BST:AFN Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below
All numbers in USD Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
BST:AFN Future Estimates Data
Date (Data in USD Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2024-12-31 1,582 1
2023-12-31 1,506 1
2022-12-31 1,422 104 110 2
2021-12-31 1,309 104 62 8
2020-12-31 1,250 81 38 8
2020-04-01
BST:AFN Past Financials Data
Date (Data in USD Millions) Revenue Cash Flow Net Income *
2019-12-31 1,131 82 -287
2019-09-30 1,011 119 65
2019-06-30 859 117 76
2019-03-31 670 102 81
2018-12-31 606 109 98
2018-09-30 593 106 78
2018-06-30 579 107 73
2018-03-31 566 115 67
2017-12-31 557 105 61
2017-09-30 543 101 65
2017-06-30 530 56 50
2017-03-31 516 43 52

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Tivity Health's earnings are expected to grow significantly at over 20% yearly.
  • Tivity Health's revenue is expected to grow by 6.6% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
BST:AFN Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below

All data from Tivity Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:AFN Future Estimates Data
Date (Data in USD Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2024-12-31
2023-12-31
2022-12-31 2.09 2.09 2.09 1.00
2021-12-31 1.24 1.71 0.65 5.00
2020-12-31 0.74 1.35 0.28 5.00
2020-04-01
BST:AFN Past Financials Data
Date (Data in USD Millions) EPS *
2019-12-31 -6.17
2019-09-30 1.45
2019-06-30 1.78
2019-03-31 1.98
2018-12-31 2.44
2018-09-30 1.96
2018-06-30 1.83
2018-03-31 1.70
2017-12-31 1.56
2017-09-30 1.66
2017-06-30 1.29
2017-03-31 1.38

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Tivity Health is expected to efficiently use shareholders’ funds in the future (Return on Equity greater than 20%).
X
Future performance checks
We assess Tivity Health's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Germany market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Germany market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Tivity Health has a total score of 5/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

AFN Past Performance

  How has Tivity Health performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Tivity Health's growth in the last year to its industry (Healthcare).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Tivity Health does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
  • Unable to compare Tivity Health's 1-year earnings growth to the 5-year average as it is not currently profitable.
  • Unable to compare Tivity Health's 1-year growth to the DE Healthcare industry average as it is not currently profitable.
Earnings and Revenue History
Tivity Health's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Tivity Health Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

BST:AFN Past Revenue, Cash Flow and Net Income Data
Date (Data in USD Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 1,131.16 -286.82 236.14
2019-09-30 1,011.41 64.66 178.89
2019-06-30 858.98 76.16 120.50
2019-03-31 670.46 80.78 55.48
2018-12-31 606.30 97.90 46.19
2018-09-30 592.62 78.00 44.99
2018-06-30 578.85 72.53 41.64
2018-03-31 565.90 67.09 37.46
2017-12-31 556.94 61.23 39.71
2017-09-30 542.52 64.73 33.93
2017-06-30 529.87 49.56 36.50
2017-03-31 515.96 52.18 38.43
2016-12-31 501.00 55.60 39.48
2016-09-30 489.55 52.66 38.96
2016-06-30 478.03 61.02 34.97
2016-03-31 466.46 52.22 37.24
2015-12-31 452.09 44.01 35.55
2015-09-30 537.75 37.39 42.80
2015-06-30 609.87 26.29 52.14
2015-03-31 677.06 14.72 56.66
2014-12-31 405.26 42.84 32.08
2014-09-30 712.28 -13.43 66.48
2014-06-30 693.24 -13.60 67.16
2014-03-31 674.90 -14.19 64.54
2013-12-31 663.29 -8.54 61.21
2013-09-30 669.23 -2.65 61.25
2013-06-30 669.17 0.58 59.54

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • It is difficult to establish if Tivity Health has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
  • It is difficult to establish if Tivity Health has efficiently used its assets last year compared to the DE Healthcare industry average (Return on Assets) as it is loss-making.
  • It is difficult to establish if Tivity Health improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
X
Past performance checks
We assess Tivity Health's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Healthcare industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Tivity Health has a total score of 0/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

AFN Health

 How is Tivity Health's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Tivity Health's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Tivity Health is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Tivity Health's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Tivity Health's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • Low level of unsold assets.
  • Debt is not covered by short term assets, assets are 0.2x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Tivity Health Company Filings, last reported 3 months ago.

BST:AFN Past Debt and Equity Data
Date (Data in USD Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 226.91 1,064.37 2.49
2019-09-30 545.40 1,056.48 6.86
2019-06-30 529.31 1,071.37 4.40
2019-03-31 517.16 1,111.84 18.79
2018-12-31 369.00 30.45 1.93
2018-09-30 346.58 52.18 1.64
2018-06-30 319.86 150.01 67.00
2018-03-31 294.58 147.83 38.79
2017-12-31 271.95 145.96 28.44
2017-09-30 262.69 149.02 4.91
2017-06-30 234.01 182.39 7.80
2017-03-31 213.97 207.30 0.66
2016-12-31 189.30 210.34 1.60
2016-09-30 162.57 250.55 0.73
2016-06-30 96.34 225.88 4.64
2016-03-31 269.37 229.75 3.09
2015-12-31 280.59 231.99 0.23
2015-09-30 296.09 252.45 1.77
2015-06-30 304.46 253.77 5.27
2015-03-31 304.06 263.85 3.75
2014-12-31 304.59 252.12 1.77
2014-09-30 299.31 257.46 1.71
2014-06-30 297.89 253.34 2.43
2014-03-31 294.87 263.39 2.16
2013-12-31 302.69 252.43 2.58
2013-09-30 307.21 261.37 2.82
2013-06-30 278.75 267.95 2.25
  • Tivity Health's level of debt (469.1%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has increased over the past 5 years (82.8% vs 469.1% today).
  • Debt is not well covered by operating cash flow (7.7%, less than 20% of total debt).
  • Tivity Health is making a loss, therefore interest payments are not well covered by earnings.
X
Financial health checks
We assess Tivity Health's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Tivity Health has a total score of 1/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

AFN Dividends

 What is Tivity Health's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
0%
Current annual income from Tivity Health dividends. Estimated to be 0% next year.
If you bought €2,000 of Tivity Health shares you are expected to receive €0 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Unable to evaluate Tivity Health's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
  • Unable to evaluate Tivity Health's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
BST:AFN Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 8 Analyst Estimates (S&P Global) See Below
Germany Healthcare Industry Average Dividend Yield Market Cap Weighted Average of 9 Stocks 2.4%
Germany Market Average Dividend Yield Market Cap Weighted Average of 323 Stocks 3.8%
Germany Minimum Threshold Dividend Yield 10th Percentile 0.9%
Germany Bottom 25% Dividend Yield 25th Percentile 1.7%
Germany Top 25% Dividend Yield 75th Percentile 5%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

BST:AFN Future Dividends Estimate Data
Date (Data in $) Dividend per Share (annual) Avg. No. Analysts
2024-12-31
2023-12-31
2022-12-31
2021-12-31 0.00 1.00
2020-12-31 0.00 1.00
2020-04-01

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Unable to perform a dividend volatility check as Tivity Health has not reported any payouts.
  • Unable to verify if Tivity Health's dividend has been increasing as the company has not reported any payouts.
Current Payout to shareholders
What portion of Tivity Health's earnings are paid to the shareholders as a dividend.
  • Unable to calculate sustainability of dividends as Tivity Health has not reported any payouts.
Future Payout to shareholders
  • No need to calculate the sustainability of Tivity Health's dividends in 3 years as they are not expected to pay a notable one for Germany.
X
Income/ dividend checks
We assess Tivity Health's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 0.9%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Tivity Health afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Tivity Health has a total score of 0/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

AFN Management

 What is the CEO of Tivity Health's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Bob Greczyn
COMPENSATION $215,007
AGE 67
TENURE AS CEO 0.1 years
CEO Bio

Mr. Robert James Greczyn, Jr., also known as Bob, serves as an Interim CEO of Tivity Health, Inc. since February 19, 2020 and serves as its Director since May 19, 2015. Mr. Greczyn serves on the Board of Vidant Medical Center, the 21st largest hospital in the U.S., and the system Board of Vidant Health, a nine hospital system based in Greenville, NC. He served as the Chief Executive Officer Emeritus at Blue Cross and Blue Shield of North Carolina. Mr. Greczyn served as Interim Chief Executive Officer and Interim President at LipoScience, Inc. from August 2013 to January 2014. He served as the Chief Executive Officer and President at CIGNA HealthCare, Inc. and Healthsource Health Plans, Inc. Mr. Greczyn is also the owner of several Mellow Mushroom franchises and Fortnight Brewery. He served as the Chief Executive Officer at Blue Cross and Blue Shield of North Carolina from April 2000 to February 1, 2010. Mr. Greczyn served as the President at Blue Cross and Blue Shield of North Carolina from 1999 to October 2009. He joined Blue Cross and Blue Shield of North Carolina, Inc. in 1998, bringing leadership experience in health care and a solid understanding of the North Carolina health care market. Mr. Greczyn serves as the Chairman of The Council for Affordable Quality Healthcare (CAQH) and is an Advisory Board and Investor at Cofounders Capital. In addition, he serves as the Campaign Chairman of Be Active North Carolina. Mr. Greczyn serves as Vice Chairman of the Board of Trustees and Trustee at East Carolina University. He serves as a Director of Trustatlantic Financial Corporation, N.C. Institute of Medicine, North Carolina Citizens for Business and Industry, Capital Food Group, LLC, CivaTech Oncology, Inc., The Venue Network and EmpowHR. He has been a Director of LipoScience, Inc. since March 28, 2011. Mr. Greczyn serves on the board of the N.C. New Schools Project. Mr. Greczyn serves on the Kate B. Reynolds Charitable Trust Advisory Board. He serves on many not for profit Boards. Mr. Greczyn served as the Chairman of East Carolina University and United Way of the Greater Triangle. He served as the Chairman of the March of Dimes' Walk America. Mr. Greczyn served as a Director of TrustAtlantic Bank. Mr. Greczyn served as a Director of MModal Inc. from October 13, 2011 to August 2012. He served on the Board of the National Blue Cross and Blue Shield Association. In his role at BCBSNC, Mr. Greczyn served on both the Board of Trustees for BCBSNC and on the Board of the national Blue Cross and Blue Shield Association. His career spanned 30 years in the health care industry. Mr. Greczyn is a Visiting Professor at the Gillings School of Global Public Health at the University of North Carolina. He is an Instrument Rated Pilot. The Cecil G. Sheps Center for Health Policy Research has named Mr. Greczyn as a Research Fellow. He earned a Master’s degree in Health Administration from the University of North Carolina at Chapel Hill and a Bachelor of Arts in Psychology from East Carolina University. Mr. Greczyn also completed the Executive Program in Health Care Finance Management at the University of North Carolina at Chapel Hill.

CEO Compensation
  • Bob's compensation has increased whilst company is loss making.
  • Bob's remuneration is lower than average for companies of similar size in Germany.
Management Team Tenure

Average tenure and age of the Tivity Health management team in years:

2
Average Tenure
52
Average Age
  • The tenure for the Tivity Health management team is about average.
Management Team

Bob Greczyn

TITLE
Interim CEO & Director
COMPENSATION
$215K
AGE
67
TENURE
0.1 yrs

Adam Holland

TITLE
Chief Financial Officer
COMPENSATION
$805K
AGE
40
TENURE
2.8 yrs

Ryan Wagers

TITLE
Chief Accounting Officer & Controller
COMPENSATION
$105K
AGE
41
TENURE
1.4 yrs

Mary Flipse

TITLE
Chief Legal & Administrative Officer
COMPENSATION
$470K
AGE
52
TENURE
2.7 yrs

Steve Janicak

TITLE
President of Healthcare Business Unit
COMPENSATION
$515K
AGE
59
TENURE
1.2 yrs

Tommy Lewis

TITLE
COO, Senior VP of Investor Relations & Interim President of the Nutrition Business Unit
TENURE
0.1 yrs

Paul Edmisten

TITLE
Chief Information Officer
TENURE
3.5 yrs

Jill Meyer

TITLE
Vice President of Corporate Communications

Bonnie Schirato

TITLE
Vice President of People & Culture

Janet Calhoun

TITLE
Chief Experience Officer
TENURE
3.3 yrs
Board of Directors Tenure

Average tenure and age of the Tivity Health board of directors in years:

4.1
Average Tenure
57
Average Age
  • The tenure for the Tivity Health board of directors is about average.
Board of Directors

Kevin Wills

TITLE
Independent Chairman
COMPENSATION
$310K
AGE
53
TENURE
4.3 yrs

Bob Greczyn

TITLE
Interim CEO & Director
COMPENSATION
$215K
AGE
67
TENURE
4.8 yrs

Brad Karro

TITLE
Independent Director
COMPENSATION
$215K
AGE
57
TENURE
5.8 yrs

Lee Shapiro

TITLE
Independent Director
COMPENSATION
$225K
AGE
63
TENURE
4.8 yrs

Paul Keckley

TITLE
Independent Director
COMPENSATION
$211K
AGE
69
TENURE
5.8 yrs

Pete Hudson

TITLE
Independent Director
COMPENSATION
$211K
AGE
53
TENURE
3.8 yrs

Sara Finley

TITLE
Independent Director
COMPENSATION
$165K
AGE
58
TENURE
1.8 yrs

Beth Jacob

TITLE
Independent Director
COMPENSATION
$171K
AGE
57
TENURE
1.8 yrs

Ben Kirshner

TITLE
Independent Director
AGE
41
TENURE
1 yrs

Dan Tully

TITLE
Independent Director
TENURE
0.6 yrs
Who owns this company?
Recent Insider Trading
  • More shares have been bought than sold by Tivity Health individual insiders in the past 3 months.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (€) Value (€)
17. Mar 20 Buy Benjamin Kirshner Individual 13. Mar 20 13. Mar 20 5,000 €3.95 €19,728
17. Mar 20 Buy Robert Greczyn Individual 13. Mar 20 13. Mar 20 39,000 €4.50 €175,361
17. Mar 20 Buy Peter Hudson Individual 13. Mar 20 13. Mar 20 40,000 €4.60 €184,192
13. Mar 20 Buy Hudson Executive Capital LP Company 11. Mar 20 11. Mar 20 4,377,655 €7.72 €33,793,352
10. Mar 20 Buy Paul Keckley Individual 06. Mar 20 09. Mar 20 15,405 €9.74 €130,877
09. Mar 20 Buy Altaris Capital Partners, LLC Company 05. Mar 20 06. Mar 20 250,000 €10.42 €2,564,522
05. Mar 20 Buy Paul Keckley Individual 03. Mar 20 03. Mar 20 4,050 €11.08 €44,887
05. Mar 20 Buy Sara Finley Individual 05. Mar 20 05. Mar 20 2,500 €10.72 €26,798
05. Mar 20 Buy Altaris Capital Partners, LLC Company 03. Mar 20 04. Mar 20 164,632 €10.76 €1,760,265
03. Mar 20 Buy Altaris Capital Partners, LLC Company 28. Feb 20 28. Feb 20 71,672 €10.89 €780,753
28. Feb 20 Buy Kevin Wills Individual 26. Feb 20 26. Feb 20 20,000 €11.10 €221,919
28. Feb 20 Buy Robert Greczyn Individual 26. Feb 20 26. Feb 20 15,000 €12.18 €182,711
28. Feb 20 Buy Lee Shapiro Individual 28. Feb 20 28. Feb 20 4,065 €10.91 €44,356
28. Feb 20 Buy Benjamin Kirshner Individual 26. Feb 20 26. Feb 20 4,000 €11.71 €46,848
03. Mar 20 Buy Paul Keckley Individual 26. Feb 20 26. Feb 20 8,200 €11.21 €91,891
28. Feb 20 Buy Bradley Karro Individual 26. Feb 20 26. Feb 20 3,500 €12.18 €42,633
28. Feb 20 Buy Beth Jacob Individual 26. Feb 20 26. Feb 20 2,000 €11.12 €22,247
28. Feb 20 Buy Adam Holland Individual 26. Feb 20 26. Feb 20 2,050 €11.25 €23,067
25. Feb 20 Sell HG Vora Capital Company 06. Jan 20 12. Feb 20 -2,935,700 €23.86 €-70,054,022
25. Feb 20 Buy HG Vora Capital Company 30. Dec 19 24. Feb 20 3,035,700 €22.96 €69,696,017
24. Feb 20 Buy Hudson Executive Capital LP Company 20. Feb 20 21. Feb 20 1,596,000 €12.70 €18,814,449
19. Dec 19 Buy Hudson Executive Capital LP Company 13. Nov 19 19. Dec 19 349,095 €18.01 €6,188,989
07. Aug 19 Buy Altaris Capital Partners, LLC Company 02. Jul 19 25. Jul 19 249,308 €14.80 €3,493,091
01. Jul 19 Buy Altaris Capital Partners, LLC Company 29. May 19 28. Jun 19 604,739 €16.49 €9,457,169
24. May 19 Buy Altaris Capital Partners, LLC Company 15. Apr 19 23. May 19 3,216,793 €20.15 €57,251,902
X
Management checks
We assess Tivity Health's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Tivity Health has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

AFN News

Simply Wall St News

AFN Company Info

Description

Tivity Health, Inc. provides fitness, nutrition, and social connection solutions in the United States. It operates through two segments, Healthcare and Nutrition. The Healthcare segment offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; Prime fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; and health plans through WholeHealth Living program, and health services, such as chiropractic care, acupuncture, physical therapy, occupational therapy, speech therapy, and others. The Nutrition segment provides weight management products and services, including Nutrisystem and South Beach Diet; and Wisely Well. This segment sells pre-packaged foods comprises frozen and non-frozen, and shelf-stable products directly to weight loss program participants primarily through the Internet and telephone; QVC, a television shopping network; and retailers. The company was formerly known as Healthways, Inc. and changed its name to Tivity Health, Inc. in January 2017. Tivity Health, Inc. was founded in 1981 and is headquartered in Franklin, Tennessee.

Details
Name: Tivity Health, Inc.
AFN
Exchange: BST
Founded: 1981
$277,230,113
48,433,780
Website: http://www.tivityhealth.com
Address: Tivity Health, Inc.
701 Cool Springs Boulevard,
Franklin,
Tennessee, 37067,
United States
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
NasdaqGS TVTY Common Stock Nasdaq Global Select US USD 13. Aug 1991
BST AFN Common Stock Boerse-Stuttgart DE EUR 13. Aug 1991
Number of employees
Current staff
Staff numbers
1,000
Tivity Health employees.
Industry
Health Care Services
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/04/01 01:00
End of day share price update: 2020/03/31 00:00
Last estimates confirmation: 2020/03/16
Last earnings filing: 2020/02/27
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.